Rashed Dewan
Director of Finance/CFO at PROFOUND MEDICAL CORP.
Net worth: 202 562 $ as of 30/03/2024
Profile
Rashed Dewan is currently working as the Chief Financial Officer at Profound Medical Corp.
He started this position in 2022.
Previously, he worked as a Controller at Profound Medical, Inc. Mr. Dewan completed his undergraduate degree at the University of Southern California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PROFOUND MEDICAL CORP
0.10% | 14/08/2023 | 23,747 ( 0.10% ) | 202 562 $ | 30/03/2024 |
Rashed Dewan active positions
| Companies | Position | Start |
|---|---|---|
| PROFOUND MEDICAL CORP. | Director of Finance/CFO | 02/03/2022 |
Former positions of Rashed Dewan
| Companies | Position | End |
|---|---|---|
Profound Medical, Inc.
 Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | - |
Training of Rashed Dewan
| University of Southern California | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROFOUND MEDICAL CORP. | Health Technology |
| Private companies | 1 |
|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Rashed Dewan
